The role of TNFR family members in regulating cell fate both in the immune system and in non-lymphoid tissues has been under extensive research for decades. Moreover, the ability of several family members (death receptors) to induce death (mainly via apoptosis) represents a promising target for cancer therapy. Many studies have focused mostly on death receptors such as TNFRI, Fas and TRAIL-R due to their strong pro-apoptotic potential.Yet, cell death can be triggered via non-classical death receptors, and the Lymphotoxin (LT) system represents a very good example of such a TNFR subfamily. Here we provide a comprehensive review of intracellular signalling pathways and cellular responses to LTspecific signalling, and compare for the first time the LT system to other TNFRs, such as CD40. Our aim is to highlight that non-classical TNFR-TNFL dyads such as the LT system demonstrate more complex, cell-type and context-specific capabilities. Understanding these complexities will permit a better understanding of the biological mechanisms via which nondeath domain-containing TNFRs induce cell death, but may also allow the design of better therapeutic strategies.

No abstract

In this review, the flow phantoms and the wall-less flow phantoms with recognized acoustic features (attenuation and speed of sound), interior properties, and dimensions of tissue were prepared, calibrated, and characterized by Doppler ultrasound (US) scanning which demands tissue-mimicking materials (TMMs). TMM phantoms are commercially available and readymade for medical US applications. Furthermore, the commercial TMM phantoms are proper for US purpose or estimation of diagnostic imaging techniques according to the chemical materials used for its preparation.

Myeloid derived suppressor cells (MDSCs) are heterogeneous subsets of  immune cells and they function to inhibit host T cells activation leading  to  tumour  growth.  Currently,  the  majority  of  studies  support  key  contributions  of  MDSCs  to  tumour  progression  via  direct  mechanisms  immune   mediated   and   indirect   mechanism   which   is     not   directly  associated with immune suppression. Due to the complexity of MDSCs  heterogeneity, the aspect of MDSCs phenotype, morphology and function  is  poorly  investigated  up  to  date.  And  for  this  reason,  this  review  will  provide  a  comprehensive  understanding  of  the  role  and  function  of  MDSCs  in  cancer  patients.  Targeting  the  immunosuppressive  cells  MDSCs may improve the efficacy of immunotherapy in cancer patients in  future.